Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors
- PMID: 38761206
- DOI: 10.1007/s00417-024-06507-9
Prevalence of Age-Related Macular Degeneration in Patients with Chronic Exposure to P2X7R Inhibitors
Abstract
Purpose: P2X7 receptor (P2X7R) is a purinergic cation channel whose activation has been linked with age-related macular degeneration (ARMD). Several nucleoside reverse transcriptase inhibitors, zidovudine (AZT), lamivudine (3TC) and abacavir (ABC), have been shown to inhibit P2X7R and improve outcomes in animal models of ARMD. Our aim is to investigate the association between chronic AZT, 3TC, and ABC therapy and ARMD in a clinical setting.
Methods: This is a retrospective cohort study comparing 445 patients with HIV and confirmed usage of AZT, 3TC, and ABC against 200 patients with HIV without usage of AZT, 3TC, and ABC and 445 non-HIV infected patients. Fundus examination and spectral domain optical coherence tomography (SD-ODT) were used to measure prevalence of early-intermediate stage ARMD, geographic atrophy, and exudative ARMD.
Results: There was no statistically significant difference in the prevalence of early-intermediate stage ARMD between the HIV infected patients with a history of AZT, 3TC, and ABC use and the HIV infected patients without AZT, 3TC, and ABC use (p = 0.887). There was also no statistically significant difference in the prevalence of geographical atrophy (p = 0.062) and exudative AMD (p > 0.999) between the HIV infected patients with a history of AZT, 3TC, and ABC use and non-HIV infected patients.
Conclusion: We did not find an effect of P2X7R inhibiting antiretrovirals usage on early-intermediate stage ARMD, geographical atrophy, or exudative ARMD. Studies with larger cohort and more rigorous medication history are needed to assess the effects on geographical atrophy or exudative ARMD.
Keywords: Age-related macular degeneration; Antiretroviral agents; Choroidal neovascularization; Geographic atrophy; P2X7 receptor; Retina.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Weill Cornell Medicine Institutional Review Board approved this study, Protocol # 22-07025078. Disclosures: Financial Interests: KDK is a consultant of Intergalactic Therapeutics.
References
-
- Mitchell P, Liew G, Gopinath B, Wong TY (2018) Age-related macular degeneration. Lancet 392(10153):1147–1159. https://doi.org/10.1016/s0140-6736(18)31550-2 - DOI - PubMed
-
- Ambati J, Atkinson JP, Gelfand BD (2013) Immunology of age-related macular degeneration. Nat Rev Immunol 13(6):438–451. https://doi.org/10.1038/nri3459 - DOI - PubMed - PMC
-
- Illes P, Müller CE, Jacobson KA et al (2021) Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. Br J Pharmacol 178(3):489–514. https://doi.org/10.1111/bph.15299 - DOI - PubMed
-
- Yang D, Elner SG, Clark AJ, Hughes BA, Petty HR, Elner VM (2011) Activation of P2X receptors induces apoptosis in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 52(3):1522–1530. Published 2011 Mar 18. https://doi.org/10.1167/iovs.10-6172
-
- Platania CBM, Drago F, Bucolo C (2022) The P2X7 receptor as a new pharmacological target for retinal diseases. Biochem Pharmacol 198:114942. https://doi.org/10.1016/j.bcp.2022.114942 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
